Date: 2025/06/03 - 18:00

Eating beans daily may help reduce inflammation, and lower cholesterol

Date: 2025/06/03 - 01:00

Food Quality May Lower Heart Disease Risk More Than Cutting Carbs, Fat

A new study suggests that food quality matters more for heart health than cutting fat or carbs. A balanced diet with high quality, unprocessed foods is best for your heart.

Date: 2025/06/02 - 21:00

How might your daily coffee influence aging?

Drinking coffee on a daily basis may increase women's chances of staying free of major chronic diseases and physical or mental limitations as they get older, a new study suggests.

Date: 2025/06/02 - 00:00

What Is ‘Skinny Tok?’ Experts Debunk the Harmful TikTok Trend for Weight Loss

"Skinny Tok" is an extreme dieting trend on TikTok that equates thinness with health. Experts warn the trend perpetuates negative body image and harmful diet culture, as extreme calorie restriction has mental and physical consequences.

Date: 2025/05/29 - 22:30

NIH scientists pioneer promising treatment for intractable cancer pain

RTX is a non-addictive pain therapy derived from a cactus-like plant.

Date: 2025/05/22 - 21:00

First blood test for Alzheimer's gets FDA greenlight: 3 things to know

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and beta-amyloid 1-42 in plasma.

Date: 2025/05/21 - 20:00

Why do some people get dementia in middle age?

Protein changes linked to RNA regulation and brain connectivity could help explain how frontotemporal dementia develops in middle age.

Date: 2025/05/20 - 19:31

Replacing 30 minutes' sitting time with exercise may prevent second heart attack

A secondary heart attack could be prevented by replacing 30 minutes of sedentary behavior with light-intensity or moderate-to-vigorous-intensity physical activity, or even with sleep.

Date: 2025/05/19 - 22:32

Zepbound More Effective for Weight Loss Than Wegovy, Eli Lilly Trial Shows

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.

Date: 2025/05/18 - 16:31

Semaglutide may reduce heart disease risk, even within first 6 months

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.